SoftOx Solutions AS is pleased to invite investors, analysts and other
stakeholders to our Strategy and Capital Markets Day, including Q3 2021 results
on Wednesday the 17th of November 2021 at 09.00 to 12.00 (CET).

Schedule:
09.00-09.10	Opening with CEO Geir Almås
09.10-10.00	Technology platform and business strategy 
10.00-11.30	Program areas for development
11.30-11.45	Finance
11.45-12.00	Q&A

The event will be held in-person at Technopolis, Martin Linges Vei 25, 1364
Fornebu, Norway. It will also be streamed live. 

Please register for the event, before 15th of November 2021, by sending an email
to ir@soft-ox.com

The Q3 2021 results will be released at 07:00 (CET) on Wednesday November 17,
2021. The interim report and related materials will be made available on:
https://soft-ox.com/financial-calendar-reports/.
For further information, please contact:

CEO Geir Almås of SoftOx Solutions AS, or
CFO Kristine Mundal Rød of SoftOx Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
BioTech company based in Oslo with the aim of helping to combat major threats to
human health, namely the emergence of antimicrobial resistance (AMR), biofilm
infections in chronic wounds and the spread of viruses. For more information on
SoftOx, visit www.soft-ox.com